Compare AKRO & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKRO | GNL |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 1.7B |
| IPO Year | 2019 | N/A |
| Metric | AKRO | GNL |
|---|---|---|
| Price | $54.65 | $8.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $73.56 | $9.00 |
| AVG Volume (30 Days) | ★ 2.4M | 1.3M |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 9.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $751,333,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.63 |
| 52 Week Low | $21.34 | $6.51 |
| 52 Week High | $58.40 | $8.40 |
| Indicator | AKRO | GNL |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 62.14 |
| Support Level | $54.30 | $8.20 |
| Resistance Level | $54.70 | $8.40 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 71.07 | 82.47 |
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.